Back to results
US 6,303,583 B1Granted
Pharmacokinetic modulating chemotherapy
AssigneesMasato Kusunoki, Taiho Pharmaceutical Co., Ltd.
InventorMasato Kusunoki
Life of this patent
Estimating the term…
Abstract
A method of treating intestinal cancer characterized by performing an adjuvant therapy comprising continuous injection of 5FU and oral administration of UFT in combination with the injection after surgical resection of a human intestinal cancer.
Claims12
A method of treating a human having an intestinal cancer characterized by performing an adjuvant therapy comprising continuous injection of 5-fluorouracil (5FU) for 3 to 48 hours once a week and oral administration of a mixture of 1-(tetrahydrofuryl)-5-fluorouracil and uracil (UFT) one to four times a day for 3 to 7 days per week.
Dependencies are inferred from the claim text.